Pharmacology & Therapeutics

4.4k papers and 337.9k indexed citations i.

About

The 4.4k papers published in Pharmacology & Therapeutics in the last decades have received a total of 337.9k indexed citations. Papers published in Pharmacology & Therapeutics usually cover Molecular Biology (2.0k papers), Oncology (661 papers) and Cellular and Molecular Neuroscience (657 papers) specifically the topics of Receptor Mechanisms and Signaling (381 papers), Neuroscience and Neuropharmacology Research (287 papers) and Pharmacogenetics and Drug Metabolism (194 papers). The most active scholars publishing in Pharmacology & Therapeutics are Paul B. Fisher, John Whysner, Amirhossein Sahebkar, Shanta J. Persaud and Devanand Sarkar.

In The Last Decade

Fields of papers published in Pharmacology & Therapeutics

Since Specialization
EngineeringComputer SciencePhysics and AstronomyMathematicsEarth and Planetary SciencesEnergyEnvironmental ScienceMaterials ScienceChemical EngineeringChemistryAgricultural and Biological SciencesVeterinaryDecision SciencesArts and HumanitiesBusiness, Management and AccountingSocial SciencesPsychologyEconomics, Econometrics and FinanceHealth ProfessionsDentistryMedicineBiochemistry, Genetics and Molecular BiologyNeuroscienceNursingImmunology and MicrobiologyPharmacology, Toxicology and Pharmaceutics

This network shows the specialization of papers published in Pharmacology & Therapeutics. Nodes represent fields, and links connect fields that are likely to share authors.

Countries where authors publish in Pharmacology & Therapeutics

Since Specialization
Total citations of papers

This map shows the geographic distribution of research published in Pharmacology & Therapeutics. It shows the number of citations received by papers published by authors working in each country. You can also color the map by specialization and compare the number of papers published in Pharmacology & Therapeutics with the expected number of papers based on a country's size and research output (numbers larger than one mean the country's share of papers is larger than expected).

Rankless by CCL
2025